Stoll B A
Oncology Department, St Thomas' Hospital, London, UK.
Int J Obes Relat Metab Disord. 2002 Jun;26(6):747-53. doi: 10.1038/sj.ijo.0801998.
A majority of prospective studies show breast cancer risk to be higher in obese postmenopausal women with upper abdominal adiposity than in those with overall adiposity. The evidence is more limited and inconsistent in the case of premenopausal women. The review examines evidence that aberrant insulin signalling may be involved in the promotion of mammary carcinogenesis. The aetiology and concomitants of abdominal visceral obesity are examined.
Clinical and experimental evidence suggests that the higher breast cancer risk associated with greater abdominal visceral obesity may be related to aberrant insulin signalling through the insulin receptor substrate 1 pathway, leading to insulin resistance, hyperinsulinaemia and increased concentrations of endogenous oestrogen and androgen. The putative role of aberrant insulin signalling in the promotion of mammary carcinogenesis may help to explain clinical relationships between breast cancer risk and age at menarche, pregnancies and onset of obesity.
Overall adiposity in women adversely affects breast cancer risk mainly by greater exposure of mammary epithelial tissue to endogenous oestrogen. Upper abdominal adiposity appears to involve an additional effect related to the presence of insulin resistance. Aetiological factors in the development of hyperinsulinaemic insulin resistance are still uncertain but may involve aberrant susceptibility genes in adipocyte insulin receptors or in the insulin receptor substrate 1 pathway. Epigenetic factors are also likely to contribute, including high free fatty acid levels and obesity. Dietary fatty acids, particularly polyunsaturated fatty acids, are known to regulate adipocyte differentiation through the nuclear peroxisome proliferator-activated receptor gamma, and may also have a role in insulin resistance. These aetiological factors are likely to be relevant to the high risk of postmenopausal breast cancer in industrialised Western populations.
大多数前瞻性研究表明,绝经后上腹部肥胖的肥胖女性患乳腺癌的风险高于全身肥胖的女性。对于绝经前女性,证据更为有限且不一致。本综述考察了异常胰岛素信号可能参与促进乳腺癌发生的证据。同时研究了腹部内脏肥胖的病因及相关因素。
临床和实验证据表明,与更大的腹部内脏肥胖相关的较高乳腺癌风险可能与通过胰岛素受体底物1途径的异常胰岛素信号有关,导致胰岛素抵抗、高胰岛素血症以及内源性雌激素和雄激素浓度增加。异常胰岛素信号在促进乳腺癌发生中的假定作用可能有助于解释乳腺癌风险与初潮年龄、妊娠及肥胖发病之间的临床关系。
女性的全身肥胖主要通过使乳腺上皮组织更多地暴露于内源性雌激素而对乳腺癌风险产生不利影响。上腹部肥胖似乎还涉及与胰岛素抵抗存在相关的额外影响。高胰岛素血症性胰岛素抵抗发生发展的病因因素仍不确定,但可能涉及脂肪细胞胰岛素受体或胰岛素受体底物1途径中的异常易感基因。表观遗传因素也可能起作用,包括高游离脂肪酸水平和肥胖。已知膳食脂肪酸,尤其是多不饱和脂肪酸,可通过核过氧化物酶体增殖物激活受体γ调节脂肪细胞分化,也可能在胰岛素抵抗中起作用。这些病因因素可能与西方工业化人群绝经后乳腺癌的高风险相关。